Brooks Laboratories Limited has incorporated a wholly owned subsidiary named Abridge Speciality Limited on July 2, 2026. The Certificate of Incorporation was issued by the Ministry of Corporate Affairs on the same day.
Subsidiary Details
- Name: Abridge Speciality Limited (ASL)
- Incorporation Date: July 2, 2026
- Relationship: Wholly Owned Subsidiary (WOS)
- Authorized Share Capital: ₹1,00,000 (Rupees One Lakh)
- Business Operations: Yet to commence operations
- Industry: Manufacturing and Marketing of Pharmaceuticals and related products
- Turnover/Net Worth: Not applicable as it is a newly incorporated company
Ownership Structure
- Brooks Laboratories Limited holds 100% share capital of Abridge Speciality Limited
- The initial share capital was subscribed at face value
- The subsidiary is considered a Related Party under SEBI regulations
Strategic Purpose
The incorporation aligns with the company's strategic objective to expand its business operations.
Additional Information
- No governmental or regulatory approvals were required for the incorporation
- No historical financial data available as the subsidiary is newly formed
- The information is being made available on the company's website